Cardioprotective Effect of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Is Mediated by Sarcolemmal but Not Mitochondrial ATP-Sensitive Potassium Channels in Rats with Systemic Inflammation. [PDF]
Borshchev YY +9 more
europepmc +1 more source
The development of a Community Service Announcement to raise awareness of the Home Medicines Review health service program. [PDF]
Quek HW +16 more
europepmc +1 more source
Weighted Ensemble Simulations Reveal Novel Conformations and Modulator Effects in Hepatitis B Virus Capsid Assembly. [PDF]
Lynch DL, Pavlova A, Fan Z, Gumbart JC.
europepmc +1 more source
[Determination of 22 organophosphates and their metabolites and 11 phthalate metabolites in human whole blood by ultra performance liquid chromatography-tandem mass spectrometry]. [PDF]
Shi FY, Xu HY, Li JH, Xu MY.
europepmc +1 more source
Implementing pharmacist-led home medicines reviews within fracture liaison services for better post-fracture care: a qualitative study of patient and practitioner experience. [PDF]
Bennett MJ +4 more
europepmc +1 more source
[Malignant histiocytosis (histiocytic medullary reticulosis, HMR)].
E, Stojimirović +2 more
openaire +1 more source
Related searches:
The effectiveness of the hydroxymethylated resorcinol (HMR) and the novolak-based HMR (n-HMR) primers to enhance bond durability of Eucalyptus globulus glulams was evaluated according to EN 391 (Delamination) and EN 392 (Shear strength) for outdoor load-bearing timber structures (Service Class 3).
Klaus Richter
exaly +2 more sources
Inhibition of I Ks channels by HMR 1556
Naunyn-Schmiedeberg's Archives of Pharmacology, 2000Chromanol HMR 1556 [(3R,4S)-(+)-N-[3-hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy)chroman-4-yl]-N-methylmethanesulfonamide], a novel inhibitor of the slow component of the delayed outward current in heart muscle cells (IKs), has been characterized in several in-vitro systems.
Heinz Gögelein +2 more
exaly +3 more sources
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004)
Antimicrobial Agents and Chemotherapy, 1997HMR 3647 (RU 66647) and HMR 3004 (RU 64004), two ketolides, had MICs at which 50% of the strains are inhibited (MIC50s) of 0.06 to 0.125 microg/ml and MIC90s of 16.0 microg/ml against 352 anaerobes. MIC50s and MIC90s of erythromycin, azithromycin, clarithromycin, and roxithromycin were 0.5 to 2.0 microg/ml and 32.0 to >64.0 microg/ml, respectively ...
L M, Ednie, M R, Jacobs, P C, Appelbaum
openaire +2 more sources
Telithromycin (HMR 3647): The first ketolide antibiotic
Drugs of Today, 2001Telithromycin, the first ketolide antibiotic to undergo clinical development, has been specifically designed to treat community-acquired respiratory tract infections, including those caused by resistant pathogens. Like macrolides, telithromycin inhibits protein synthesis by acting mainly on the 50S ribosomal subunit.
Yan-Qiong, Xiong, Thuan P., Le
openaire +2 more sources

